Knopman, D. S. et al. Alzheimer disease. Nat. Rev. Dis. Primers 7, 33 (2021).
Schneider, J. A., Arvanitakis, Z., Leurgans, S. E. & Bennett, D. A. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann. Neurol. 66, 200–208 (2009).
Yaffe, K., Barnes, D., Nevitt, M., Lui, L. -Y. & Covinsky, K. A prospective study of physical activity and cognitive decline in elderly women: women who walk. Arch. Intern. Med. 161, 1703–1708 (2001).
Liu, Y. et al. The beneficial effects of physical exercise in the brain and related pathophysiological mechanisms in neurodegenerative diseases. Lab. Invest. 99, 943–957 (2019).
Walk, W. W. A prospective study of physical activity and cognitive decline in elderly women. Arch. Intern. Med. 161, 1703–1708 (2001).
Matura, S. et al. Effects of aerobic exercise on brain metabolism and grey matter volume in older adults: results of the randomised controlled SMART trial. Transl. Psych. 7, e1172–e1172 (2017).
Erickson, K. I. et al. Exercise training increases size of hippocampus and improves memory. Proc. Natl Acad. Sci. USA 108, 3017–3022 (2011).
Heyn, P., Abreu, B. C. & Ottenbacher, K. J. The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis. Arch. Phys. Med. Rehab. 85, 1694–1704 (2004).
Argilés, J. M., Campos, N., Lopez-Pedrosa, J. M., Rueda, R. & Rodriguez-Mañas, L. Skeletal muscle regulates metabolism via interorgan crosstalk: roles in health and disease. J. Am. Med. Direct. Assoc. 17, 789–796 (2016).
Delezie, J. & Handschin, C. Endocrine crosstalk between skeletal muscle and the brain. Front. Neurol. 9, 698 (2018).
Pedersen, L. & Hojman, P. Muscle-to-organ cross talk mediated by myokines. Adipocyte 1, 164–167 (2012).
Pedersen, B. K. Physical activity and muscle-brain crosstalk. Nat. Rev. Endocrinol. 15, 383–392 (2019).
Pedersen, B. K. & Febbraio, M. Muscle-derived interleukin-6-a possible link between skeletal muscle, adipose tissue, liver, and brain. Brain Behav. Immun. 19, 371–376 (2005).
Gómez-Rubio, P. & Trapero, I. The effects of exercise on IL-6 levels and cognitive performance in patients with schizophrenia. Diseases 7, 11 (2019).
Joisten, N. et al. Exercise and the kynurenine pathway: current state of knowledge and results from a randomized cross-over study comparing acute effects of endurance and resistance training. Exerc. Immunol. Rev. 26, 24–42 (2020).
Agudelo, L. Z. et al. Skeletal muscle PGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell 159, 33–45 (2014).
Lourenco, M. V. et al. Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models. Nat. Med. 25, 165–175 (2019).
Islam, M. R. et al. Exercise hormone irisin is a critical regulator of cognitive function. Nat. Metab. 3, 1058–1070 (2021).
Moon, H. Y. et al. Running-induced systemic cathepsin B secretion is associated with memory function. Cell Metab. 24, 332–340 (2016).
Pegtel, D. M. & Gould, S. J. Exosomes. Annu. Rev. Biochem. 88, 487–514 (2019).
Estrada, A. L. et al. Extracellular vesicle secretion is tissue-dependent ex vivo and skeletal muscle myofiber extracellular vesicles reach the circulation in vivo. Am. J. Physiol. Cell Physiol. 322, C246–c259 (2022).
Liu, P. P., Xie, Y., Meng, X. Y. & Kang, J. S. History and progress of hypotheses and clinical trials for Alzheimer’s disease. Signal Transduct. Target. Ther. 4, 29 (2019).
Davies, P. & Maloney, A. J. Selective loss of central cholinergic neurons in Alzheimer’s disease. Lancet 2, 1403 (1976).
Selkoe, D. J. The molecular pathology of Alzheimer’s disease. Neuron 6, 487–498 (1991).
Leng, F. & Edison, P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?. Nat. Rev. Neurol. 17, 157–172 (2021).
Rajesh, Y. & Kanneganti, T. D. Innate immune cell death in neuroinflammation and Alzheimer’s disease. Cells https://doi.org/10.3390/cells11121885 (2022).
Sarlus, H. & Heneka, M. T. Microglia in Alzheimer’s disease. J. Clin. Invest. 127, 3240–3249 (2017).
Lv, Z. et al. Clearance of β-amyloid and synapses by the optogenetic depolarization of microglia is complement selective. Neuron 112, 740–754 (2024).
Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer’s disease. Cell 169, 1276–1290 (2017).
Zhou, Y. et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease. Nat. Med. 26, 131–142 (2020).
Rangaraju, S. et al. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease. Mol. Neurodegener. 13, 24 (2018).
Wei, J. -a. et al. Physical exercise modulates the microglial complement pathway in mice to relieve cortical circuitry deficits induced by mutant human TDP-43. Cell Rep. https://doi.org/10.1016/j.celrep.2023.112240 (2023).
Li, C. et al. Regulation of microglia phagocytosis and potential involvement of exercise. Front. Cell Neurosci. 16, 953534 (2022).
Witcher, K. G. et al. Traumatic brain injury causes chronic cortical inflammation and neuronal dysfunction mediated by microglia. J. Neurosci. 41, 1597–1616 (2021).
Zhou, T. et al. Microglial debris is cleared by astrocytes via C4b-facilitated phagocytosis and degraded via RUBICON-dependent noncanonical autophagy in mice. Nat. Commun. 13, 6233 (2022).
Huang, Y. et al. Repopulated microglia are solely derived from the proliferation of residual microglia after acute depletion. Nat. Neurosci. 21, 530–540 (2018).
Liu, L. et al. Exercise reprograms the inflammatory landscape of multiple stem cell compartments during mammalian aging. Cell Stem Cell 30, 689–705 (2023).
Xu, J. et al. Cold-activated brown fat-derived extracellular vesicle-miR-378a-3p stimulates hepatic gluconeogenesis in male mice. Nat. Commun. 14, 5480 (2023).
Li, M. E. et al. Role of p110a subunit of PI3-kinase in skeletal muscle mitochondrial homeostasis and metabolism. Nat. Commun. 10, 3412 (2019).
Kamei, Y. et al. A forkhead transcription factor FKHR up-regulates lipoprotein lipase expression in skeletal muscle. FEBS Lett. 536, 232–236 (2003).
Teaney, N. A. & Cyr, N. E. FoxO1 as a tissue-specific therapeutic target for type 2 diabetes. Front. Endocrinol. 14, 1286838 (2023).
Sanaeifar, F. et al. Beneficial effects of physical exercise on cognitive-behavioral impairments and brain-derived neurotrophic factor alteration in the limbic system induced by neurodegeneration. Exp. Gerontol. 195, 112539 (2024).
Sanders, L. M. J. et al. Effects of low- and high-intensity physical exercise on physical and cognitive function in older persons with dementia: a randomized controlled trial. Alzheimers Res. Ther. 12, 28 (2020).
Gallardo-Gómez, D. et al. Optimal dose and type of exercise to improve cognitive function in older adults: a systematic review and bayesian model-based network meta-analysis of RCTs. Ageing Res. Rev. 76, 101591 (2022).
Karssemeijer, E. G. A. et al. Positive effects of combined cognitive and physical exercise training on cognitive function in older adults with mild cognitive impairment or dementia: a meta-analysis. Ageing Res. Rev. 40, 75–83 (2017).
Groot, C. et al. The effect of physical activity on cognitive function in patients with dementia: a meta-analysis of randomized control trials. Ageing Res. Rev. 25, 13–23 (2016).
Wang, X. et al. Long-term running exercise alleviates cognitive dysfunction in APP/PSEN1 transgenic mice via enhancing brain lysosomal function. Acta Pharmacol. Sin. 43, 850–861 (2022).
Zhang, S. -s et al. Long-term running exercise improves cognitive function and promotes microglial glucose metabolism and morphological plasticity in the hippocampus of APP/PS1 mice. J. Neuroinflammation 19, 34 (2022).
Tapia-Rojas, C., Aranguiz, F., Varela-Nallar, L. & Inestrosa, N. C. Voluntary running attenuates memory loss, decreases neuropathological changes and induces neurogenesis in a mouse model of Alzheimer’s disease. Brain Pathol. 26, 62–74 (2016).
Geard, D., Reaburn, P. R. J., Rebar, A. L. & Dionigi, R. A. Masters athletes: exemplars of successful aging?. J. Aging Phys. Act. 25, 490–500 (2017).
Abou-Dest, A., Albinet, C. T., Boucard, G. & Audiffren, M. Swimming as a positive moderator of cognitive aging: a cross-sectional study with a multitask approach. J. Aging Res. 2012, 273185 (2012).
Sato, D. et al. Elite competitive swimmers exhibit higher motor cortical inhibition and superior sensorimotor skills in a water environment. Behav. Brain Res. 395, 112835 (2020).
Miyoshi, T., Nakazawa, K., Tanizaki, M., Sato, T. & Akai, M. Altered activation pattern in synergistic ankle plantarflexor muscles in a reduced-gravity environment. Gait Posture 24, 94–99 (2006).
Frederiksen, K. S., Gjerum, L., Waldemar, G. & Hasselbalch, S. G. Effects of physical exercise on Alzheimer’s disease biomarkers: a systematic review of intervention studies. J. Alzheimers Dis. 61, 359–372 (2018).
Law, L. L. et al. Moderate intensity physical activity associates with CSF biomarkers in a cohort at risk for Alzheimer’s disease. Alzheimers Dement. 10, 188–195 (2018).
Prado Lima, M. G. et al. Environmental enrichment and exercise are better than social enrichment to reduce memory deficits in amyloid beta neurotoxicity. Proc. Natl Acad. Sci. USA 115, E2403–e2409 (2018).
Jiao, S. S. et al. Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer’s disease. Transl. Psychiatry 6, e907–e907 (2016).
Hook, V. et al. Cathepsin B in neurodegeneration of Alzheimer’s disease, traumatic brain injury, and related brain disorders. Biochim. Biophys. Acta Proteins Proteom. 1868, 140428 (2020).
Severinsen, M. C. K. & Pedersen, B. K. Muscle-organ crosstalk: the emerging roles of myokines. Endocr. Rev. 41, 594–609 (2020).
Shao, X. et al. Atrophic skeletal muscle fibre-derived small extracellular vesicle miR-690 inhibits satellite cell differentiation during ageing. J. Cachexia Sarcopenia Muscle 13, 3163–3180 (2022).
Sheng, R. et al. Muscle-bone crosstalk via endocrine signals and potential targets for osteosarcopenia-related fracture. J. Orthop. Translat. 43, 36–46 (2023).
Ma, S. et al. Skeletal muscle-derived extracellular vesicles transport glycolytic enzymes to mediate muscle-to-bone crosstalk. Cell Metab. 35, 2028–2043 (2023).
Stanford, K. I. & Goodyear, L. J. Muscle-adipose tissue cross-talk. Cold Spring Harb. Perspect. Med. https://doi.org/10.1101/cshperspect.a029801 (2018).
Butovsky, O. & Weiner, H. L. Microglial signatures and their role in health and disease. Nat. Rev. Neurosci. 19, 622–635 (2018).
Long, H. Z. et al. The role of microglia in Alzheimer’s disease from the perspective of immune inflammation and iron metabolism. Front. Aging Neurosci. 14, 888989 (2022).
Gao, C., Jiang, J., Tan, Y. & Chen, S. Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct. Target. Ther. 8, 359 (2023).
Deczkowska, A. et al. Disease-associated microglia: a universal immune sensor of neurodegeneration. Cell 173, 1073–1081 (2018).
Song, W. M. & Colonna, M. The identity and function of microglia in neurodegeneration. Nat. Immunol. 19, 1048–1058 (2018).
Li, H. & Eyo, U. B. The diversity, destiny, and memory of DAMs. Immunity 57, 200–202 (2024).
Spangenberg, E. et al. Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer’s disease model. Nat. Commun. 10, 3758 (2019).
Fan, Z., Brooks, D. J., Okello, A. & Edison, P. An early and late peak in microglial activation in Alzheimer’s disease trajectory. Brain 140, 792–803 (2017).
Wang, R., Zhan, Y., Zhu, W., Yang, Q. & Pei, J. Association of soluble TREM2 with Alzheimer’s disease and mild cognitive impairment: a systematic review and meta-analysis. Front. Aging Neurosci. 16, 1407980 (2024).
Kumar, M. A. et al. Extracellular vesicles as tools and targets in therapy for diseases. Signal Transduct. Target. Ther. 9, 27 (2024).
Xu, L., Yang, B. F. & Ai, J. MicroRNA transport: a new way in cell communication. J. Cell. Physiol. 228, 1713–1719 (2013).
Machado, I. F., Teodoro, J. S., Palmeira, C. M. & Rolo, A. P. miR-378a: a new emerging microRNA in metabolism. Cell. Mol. Life Sci. 77, 1947–1958 (2020).
Krist, B., Florczyk, U., Pietraszek-Gremplewicz, K., Józkowicz, A. & Dulak, J. The role of miR-378a in metabolism, angiogenesis, and muscle biology. Int. J. Endocrinol. 2015, 281756 (2015).
Zhang, Y. et al. miR-378 activates the pyruvate-PEP futile cycle and enhances lipolysis to ameliorate obesity in mice. EBioMedicine 5, 93–104 (2016).
Yang, D. et al. Lipid metabolism and storage in neuroglia: role in brain development and neurodegenerative diseases. Cell Biosci. 12, 106 (2022).
Liu, W. et al. Hepatic miR-378 targets p110α and controls glucose and lipid homeostasis by modulating hepatic insulin signalling. Nat. Commun. 5, 5684 (2014).
Shao, D. et al. PGC-1 beta-regulated mitochondrial biogenesis and function in myotubes is mediated by NRF-1 and ERR alpha. Mitochondrion 10, 516–527 (2010).
Peruzzotti-Jametti, L. et al. Mitochondrial complex I activity in microglia sustains neuroinflammation. Nature 628, 195–203 (2024).
Wang, H., Yu, S. Y., Nielsen, S., Wang, X. & Zhao, W. W. Mitochondrial complex I: the key to sustained microglia activation and neuroinflammation maintenance. Mil. Med. Res. 11, 47 (2024).
Buchman, A. S. & Bennett, D. A. Loss of motor function in preclinical Alzheimer’s disease. Expert Rev. Neurother. 11, 665–676 (2011).
Kumari, S., Dhapola, R. & Reddy, D. H. Apoptosis in Alzheimer’s disease: insight into the signaling pathways and therapeutic avenues. Apoptosis 28, 943–957 (2023).
de Jong, B., Barros, E. R., Hoenderop, J. G. J. & Rigalli, J. P. Recent advances in extracellular vesicles as drug delivery systems and their potential in precision medicine. Pharmaceutics https://doi.org/10.3390/pharmaceutics12111006 (2020).
Ennerfelt, H. et al. SYK coordinates neuroprotective microglial responses in neurodegenerative disease. Cell 185, 4135–4152 (2022).
Shi, T. et al. Osteocyte-derived sclerostin impairs cognitive function during ageing and Alzheimer’s disease progression. Nat. Metab. 6, 531–549 (2024).
Zhang, Q., Jeppesen, D. K., Higginbotham, J. N., Franklin, J. L. & Coffey, R. J. Comprehensive isolation of extracellular vesicles and nanoparticles. Nat. Protoc. 18, 1462–1487 (2023).
Tabebordbar, M. et al. Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species. Cell 184, 4919–4938 (2021).
Du, S. et al. Primary microglia isolation from postnatal mouse brains. J. Vis. Exp. https://doi.org/10.3791/62237 (2021).
Stine, W. B., Jungbauer, L., Yu, C. & LaDu, M. J. Preparing synthetic Aβ in different aggregation states. Methods Mol. Biol. 670, 13–32 (2011).
Bouter, Y. et al. N-truncated amyloid beta (Aβ) 4–42 forms stable aggregates and induces acute and long-lasting behavioral deficits. Acta Neuropathol. 126, 189–205 (2013).
Zhang, S. F., Chen, J. C., Zhang, J. & Xu, J. G. miR-181a involves in the hippocampus-dependent memory formation via targeting PRKAA1. Sci. Rep. 7, 8480 (2017).
Bevins, R. A. & Besheer, J. Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study ‘recognition memory’. Nat. Protoc. 1, 1306–1311 (2006).